Biology of Blood and Marrow Transplantation
Volume 14, Issue 2 , Pages 208-219, February 2008

Elevated Numbers of Immature/Transitional CD21 B Lymphocytes and Deficiency of Memory CD27+ B Cells Identify Patients with Active Chronic Graft-versus-Host Disease

  • Hildegard T. Greinix

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationCorrespondence and reprint requests: Hildegard T. GREINIX, MD, Medizinische Universitaet Wien, Klinik fuer Innere Medizin I, Knochenmarktransplantation, Waehringer Guertel 18-20 A-1090 Vienna, Austria. Phone: +43-1-40400-5706 Fax: +43-1-40400 2511.
  • ,
  • David Pohlreich

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria
  • ,
  • Michal Kouba

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria
  • ,
  • Ulrike Körmöczi

      Affiliations

    • Institute of Immunology, Medical University of Vienna, Vienna, Austria
  • ,
  • Imke Lohmann

      Affiliations

    • Institute of Immunology, Medical University of Vienna, Vienna, Austria
  • ,
  • Karin Feldmann

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria
  • ,
  • Christoph Zielinski

      Affiliations

    • Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria
  • ,
  • Winfried F. Pickl

      Affiliations

    • Institute of Immunology, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationWinfried F. PICKL, MD Institut fuer Immunologie, Medizinische Universitaet Wien, Borschkegasse, 8°, A-1090 Vienna, Austria, Phone: +43-1-4277-64945, Fax: +43-1-4277-9649.

Abstract 

Chronic graft-versus-host disease (cGVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (HSCT) and a leading cause of non-relapse mortality (NRM). Currently, biology-based markers are lacking both for diagnosis and for monitoring the activity of cGVHD. Seventy patients who received HSCT were enrolled in a pilot study, including 21 without cGVHD and 49 with active or resolved cGVHD. Evaluations were comprised of clinical parameters including cGVHD severity and infections. Peripheral blood cells were analyzed by multi-parameter flow cytometry. The CD19+ B cell compartment was further subdivided by staining for surface IgD, CD21 and CD27. No significant differences in absolute B, T, and natural killer (NK) cell numbers were observed between the groups with and without cGVHD. However, elevated numbers (>15% of B lymphocytes) of immature/transitional CD19+/CD21- B cells were associated with the occurrence of severe infections (P = .003). Most significantly, all patients with active cGVHD and elevated numbers of CD19+/CD21- B lymphocytes experienced severe infections (P = .00016). The numbers of both non-class-switched and class-switched memory B cells were significantly lower in patients with active cGVHD when compared to patients who never experienced cGVHD (P = .002 and P = .001). Perturbation of circulating B lymphocyte compartments may serve as a novel biomarker for monitoring cGVHD activity and its impact on the immune system. A prospective study on unselected patients assessed serially for B cell reconstitution after HSCT is warranted.

Key Words: chronic GVHD, immature/transitional and memory B lymphocytes

 

PII: S1083-8791(07)00539-3

doi:10.1016/j.bbmt.2007.10.009

Biology of Blood and Marrow Transplantation
Volume 14, Issue 2 , Pages 208-219, February 2008